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ABSTRACT 
Hapten-radioimmunoassay may be used for sensitive and specific 
quantitation of low molecular weight substances which can be made 
immunogenic by conjugation to a protein. This method, which involves 
radioiodination of the protein-portion of the conjugate, has been 
used for quantitation of non-conjugated estrogenic steroids. 
Radioimmunoassay procedures have been applied to the estimation 
of proteins and large polypeptides (1, 2) since these substances 
elicit specific antisera and contain tyrosine residues which may be 
radioiodinated to give preparations with high specific activity. This 
approach has been extended to similar labeled peptides which, although 
non-immunogenic by themselves become immunogenic when conjugated to a 
protein (3, 4). Non-immunological radioassays have been developed for 
estimation of certain steroids and vitamins for which specific natur- 
ally occurring binding agents were availa ble (5-13). In this approach, 
termed competitive protein binding (5, 6) , saturation analysis (7, 8) 
or radio-ligand binding (g), the labeled steroid or vitamin (ligand) 
has been allowed to compete with varying amounts of unlabeled ligand 
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for available reactive sites on the binding agent. The obvious lim- 
itation of this approach as a general method is the need for specific, 
stable and avid binding agents and radioisotopically labeled, high 
specific activity ligands. This communication describes a radioimmuno- 
assay procedure applicable for any small molecular weight substance 
which can act as a haDten (immunogenic following conjugation to a 
protein). In this approach the protein portion of the conjugate is 
radioiodinated and used in combination with antibodies specific for the 
hapten for radioimmunoassay of free hapten. The feasibility of the 
method was established in the following preliminary studies with es- 
tradiol-17B (E2) which was conjugated to bovine serum albumin (BSA) 
through its chloro-derivative. That antibodies against steroid hor- 
mones can be obtained by immunization with steroid-protein conjugates 
has been well documented (14-M). The double antibody radioimmunoassay 
and radioiodination procedures used in this study were similar to those 
reported from this laboratory for several protein hormones (19-21). 
METHOX 
One gram of E2 was dissolved in 200 ml dry ether and phosgene gas 
bubbled through the sol-;ition for one hour at room temperature. Twenty- 
four hours later, nitrogen gas was bubbled into the solution for two 
hours to remove excess phosgene. Ether was then evaporated in vacuum 
and the resulting chloro-derivative was crystallized from acetone. It 
was not determined whether the resulting chlorocarbonate was at the 3, 
the 17 or both of these carbons. One hundred five mg of BSA (Dentex, 
crystalline) was dissolved in 2.5 ml of water and the pH was adjusted 
to 9.0 by the addition of 9.48 ml of 1N NaOH. One hundred mg of the 
chloro-derivative dissolved in 2 ml of dioxane was added gradually to 
the protein solution, and stirring was continual for 4 hours at 0 C. 
The product (E2-BSA) was dialyzed first against 60% aqueous dioxane 
and then exhaustively against water, and lyophilized. 
For the preparation of antiserum each rabbit was injected in the 
foot pads and multiple subcutaneous sites with 1 ml of complete Freund's 
adjuvant containing 1 mg of E2-BSA. This procedure was repeated twice 
at three week intervals and after the third injection the animals were 
bled weekly. 
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E2-BSA was radioiodinated with 131 I by a modification of the 
method of Greenwood et al (22) as described previously (19-Z.). A -- 
double antibody radioimmunoassay procedure was employed in the presence 
of excess BSA in order to suppress antibodies directed against this 
portion of the conjugate. Each assay tube contained 0.5 ml of 5% BSA 
in 0.01 M phosphate-buffered 0.14 M NaCL, pK 7.0 (PBS) with variable 
amounts of the test steroid and 0.2 ml of antibody diluted in 1:400 
normal rabbit ser 
0.1 ml of E2-BSA-'1 
The tubes were left at k°C for 24 hours and then 
I (0.2 wg) was added. After an additional 24 
hours at k°C, 0.2 ml of sheep anti-rabbit gamma globulin serum was added 
at a dilution capable of maximally precipitating the rabbit gamma globu- 
lin in each tube. After three days the tubes were centrifuged and the 
radio-activity of the precipitates was counted. For standards, various 
steroids in an amount not to exceed 10 mg were dissolved in 1 ml of 
ether to which was added 2 ml of ethanol followed by 5% BSA-PBS to give 
a final volume of 100 ml. All subsequent dilutions were also made in 
5% BSA-PBS. 
RESULTS 
As shown in Table 1, with anti-E2-BSA added at a dilution of 1:4000, 
31% of E2-BSA-131 I with a specific activity of 330 mC/mg was bound by 
antibody. More extensive iodination resulted in a loss in the kmuno- 
reactivity of the conjugate. This suggests that as the specific activ- 
ity of the conjugate increased, iodination of the phenolic ring A of the 
estradiol occurred which decreased its reactivity with the antiserum. 
TABLE 1 
~~OR~AC~I~I~Y OF E2-BSA- 131 I CO~~GAT~S PREPARED WITR 





Amount of Amount of Resulting % of 
Chloromine-T 





2.5 60 1.0 330 31.1 
2.5 60 6.25 1845 9.9 
1.0 60 6.25 4304 4.8 
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As illustrated in Figure 1, increasing amounts of free estradiol in 
PBS-?% BSA resulted in a progressive decrease in the amount of antibody- 
bound E2-BSA- 131 I . (The amount of radioactivity bound to antibody in 
buffer-control tubes was considered as 100%). A significant inhibition 
was obtained by 0.1 mpg of estradiol-17B (the amount which inhibited to 
the minimum value of the 95% confidence limits of the PBS-BSA control tubes). 
.Ol .I I IO 100 1000 10000 100000 
mpg/TUBE 
Figure 1. Inhibition by various steroids of the reaction between E2- 
BSA-131 I and anti-E2-BSA in the presence of excess BSA. 
See text for details. 
The relative potencies of other steroids tested, read at 78% inhib- 
ition (Figure 1) and expressed in percent equivalents of estradiol-17p, 
are as follows: estrone, 81; estradiol 17oC, 52; estriol, 12; proges- 
terone, 0.03; corticosterone, 0.02; testosterone, 0.01; cortisone, 
0.008; hydrocortisone, 0.002; and cholesterol, 0.0006. With the excep- 
tion of the estrogenic compounds, other steroids contained one 3,300th 
to one 167,OOOth the activity. 
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DISCUSSION 
The assay just described was not presented as a definitive proce- 
dure for estrogenic steroids but rather an example of the feasibility of 
hapten-radioimmunoassay. Many improvements could be made to the assay. 
Tkius , conjugates should be prepared at a single position on the steroid 
molecule, preferably at a site other than the 3 or 17 carbon to 
increase chances for obtaining a more specific antiserum (23). The ideal 
labeled preparation should have one steroid conjugated to a polypeptide 
with many tyrosine residues, such as the copolymer polytyrosine. Since, 
as indicated by the results in Table 1, iodination of the phenolic ring 
A of estradiol likely occurred, attempts could be made to protect the 
steroid during iodination by reacting it with insolubilized antibody, 
and then recovering the fully immunoreactive labeled conjugate by elu- 
tion. Attempts could also be made to obtain better antisera by immun- 
ization of more rabbits and by absorption of the antisera with insoluble 
conjugates of other steroids. Studies in progress (G.D. Niswender, T. 
Higgins, A.R. Midgley, Jr.) have indicated that it will be possible to 
use these procedures to develop a highly sensitive and specific assay 
for testosterone (24). 
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